Sugi Predict

Sugi Predict / Compounds / SCHEMBL35793

SCHEMBL35793

SCHEMBL35793

CC(C)(C)CCCCc1cccc(CCCCC(C)(C)C)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.50
▸ GABRB2 P47870 2/20 0.50
▸ ALOX5 P09917 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ IAPP P10997 4/20 0.38
▸ TYR P14679 1/20 0.37
▸ BID P55957 3/20 0.37
▸ MCL1 Q07820 3/20 0.37
▸ BCL2L1 Q07817 2/20 0.37
▸ BAK1 Q16611 2/20 0.37
▸ KAT8 Q9H7Z6 2/20 0.37
▸ PPARG P37231 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ EP300 Q09472 1/20 0.37
▸ KAT2A Q92830 1/20 0.37
▸ KAT2B Q92831 1/20 0.37
▸ KAT5 Q92993 1/20 0.37
▸ SAE1 Q9UBE0 1/20 0.37
▸ CA2 P00918 1/20 0.35
▸ LIPG Q9Y5X9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25995260 0.98 GABRA1 (0.48) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25995245 0.98 GABRA1 (0.48) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25995234 0.98 GABRA1 (0.48) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25995220 0.98 GABRA1 (0.48) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25995155 0.94 GABRA1 (0.52) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25998048 0.90 GABRA1 (0.46) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL26063014 0.88 GABRA1 (0.44) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25998385 0.88 GABRA1 (0.44) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25998492 0.88 GABRA1 (0.44) GABRA1GABRB2ALOX5PTGS2IAPP
SCHEMBL25995103 0.86 TYR (0.46) GABRA1GABRB2ALOX5PTGS2TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 — — EP claimed
US-20230390105-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC 2023-12-07 — — US claimed
EP-3787533-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY Femasys, Inc. (US) 2021-03-10 — — EP claimed
CN-110267687-A Composition and method including biodegradable cyanoacrylate 费玛塞斯公司 2019-09-20 — — CN claimed
WO-2018148453-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS, INC. (US) 2018-08-16 — — WO claimed
EP-2603552-B1 WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN ADHEZION BIOMEDICAL LLC (US) 2017-05-17 — — EP claimed
EP-2303343-B1 METHOD OF PREPARING ADHESIVE COMPOSITIONS FOR MEDICAL USE: SINGLE ADDITIVE AS BOTH THE THICKENING AGENT AND THE ACCELERATOR ADHEZION BIOMEDICAL LLC (US) 2016-01-13 — — EP claimed
US-3981813-A HYDROCARBON OILS STANDARD OIL COMPANY (INDIANA) (US) 1976-09-21 — — US claimed
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates FEMASYS INC. (US) 2026-04-21 — — US disclosed
US-12582546-B2 Methods and devices for controlled delivery FEMASYS INC. (US) 2026-03-24 — — US disclosed
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS FEMASYS INC (US) 2026-03-05 — — US disclosed
EP-4613213-A2 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS Femasys, Inc. (US) 2025-09-10 — — EP disclosed
EP-4385529-B1 DEVICES FOR CONTROLLED DELIVERY FEMASYS INC (US) 2025-07-16 — — EP disclosed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 — — EP disclosed
US-20070248486-A1 Process for Sterilization of Cyanoacrylate Adhesive Compositions and Devices CLAST TRADING LTD (CN) 2007-10-25 — — US disclosed
EP-1807121-A2 PROCESS FOR STERILIZATION OF AND CYANOACRYLATE ADHESIVE COMPOSITIONS AND DEVICES Chemence, Inc. (US) 2007-07-18 — — EP disclosed
WO-2006034064-A2 PROCESS FOR STERILIZATION OF AND CYANOACRYLATE ADHESIVE COMPOSITIONS AND DEVICES CHEMENCE INC (US) 2006-03-30 — — WO disclosed
US-20060062687-A1 Process for sterilization of and cyanoacrylate adhesives compositions and devices CLAST TRADING LTD (HK) 2006-03-23 — — US disclosed
US-20060006364-A1 Fluorene derivatives and polymers thereof CHISSO CORPORATION AND CHISSO PETROCHEMICAL CORPORATION 2006-01-12 — — US disclosed
EP-0489050-A1 ARYL ESTER AMIDE HALIDES OF PHOSPHONOUS ACID, ARYL ESTER AMIDES OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS HOECHST AKTIENGESELLSCHAFT (DE) 1992-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS PGF, ACR, FGB GABRA1 2922/4885GABRB2 2302/4885ALOX5 51/4885
US-12582546-B2 Methods and devices for controlled delivery PGF, GNRHR, LHCGR GABRA1 4277/4885GABRB2 4516/4885ALOX5 3633/4885
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates MKI67, ACR, PGF GABRA1 3094/4885GABRB2 2688/4885ALOX5 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.